Ferring Pharmaceuticals launches Nocdurna in US to treat nocturia

pharmanewsdaily- November 10, 2018 0

Ferring Pharmaceuticals has announced the launch of Nocdurna (desmopressin acetate) in the United States, marking a significant advancement in the treatment of nocturia caused by ... Read More